PKCβII inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 8, 2011, Pages 1769-1777

  Palaniyandi, Suresh Selvaraj ^a   Ferreira, Julio Cesar Batista ^a,b   Brum, Patricia Chakur ^b   Mochly Rosen, Daria ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiac remodelling; Heart failure; Inflammation; Mast cells, myocardial fibrosis; Myocardial infarction; PKC II inhibitor peptide; Protein kinase

Indexed keywords

AUTACOID; COLLAGEN; MADH2 PROTEIN, RAT; MADH3 PROTEIN, RAT; PEPTIDE; PEPTIDE FRAGMENT; PROTEIN KINASE C; PROTEIN KINASE C BETA; PROTEIN KINASE INHIBITOR; SMAD2 PROTEIN; SMAD3 PROTEIN; TAT PEPTIDE (47 57), HUMAN IMMUNODEFICIENCY VIRUS 1; TAT PEPTIDE (47-57), HUMAN IMMUNODEFICIENCY VIRUS 1; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BLOOD PRESSURE; CARDIOMEGALY; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FIBROSIS; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HEART RATE; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; RAT; WISTAR RAT;

AMINO ACID SEQUENCE; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; COLLAGEN; FIBROSIS; HEART FAILURE; HEART RATE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PEPTIDE FRAGMENTS; PEPTIDES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; SMAD2 PROTEIN; SMAD3 PROTEIN; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSFORMING GROWTH FACTOR BETA1;

MUS; RATTUS;

EID: 79960333130     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01174.x     Document Type: Article

References (36)

1. Churchill E, Budas G, Vallentin A, et al. PKC isozymes in chronic cardiac disease: possible therapeutic targets? Annu Rev Pharmacol Toxicol. 2008; 48: 569-99.
2. Palaniyandi SS, Sun L, Ferreira JC, et al. Protein kinase C in heart failure: a therapeutic target? Cardiovasc Res. 2009; 82: 229-39.
3. Hambleton M, Hahn H, Pleger ST, et al. Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure. Circulation. 2006; 114: 574-82.
4. Inagaki K, Chen L, Ikeno F, et al. Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heartin vivo. Circulation. 2003; 108: 2304-7.
5. Inagaki K, Iwanaga Y, Sarai N, et al. Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta. J Mol Cell Cardiol. 2002; 34: 1377-85.
6. Inagaki K, Koyanagi T, Berry NC, et al. Pharmacological inhibition of epsilon-protein kinase C attenuates cardiac fibrosis and dysfunction in hypertension-induced heart failure. Hypertension. 2008; 51: 1565-9.
7. Braun MU, Mochly-Rosen D. Opposing effects of delta- and zeta-protein kinase C isozymes on cardiac fibroblast proliferation: use of isozyme-selective inhibitors. J Mol Cell Cardiol. 2003; 35: 895-903.
8. Bowling N, Walsh RA, Song G, et al. Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation. 1999; 99: 384-91.
9. Sabri A, Steinberg SF. Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure. Mol Cell Biochem. 2003; 251: 97-101.
10. Simonis G, Briem SK, Schoen SP, et al. Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy. Mol Cell Biochem. 2007; 305: 103-11.
11. Wakasaki H, Koya D, Schoen FJ, et al. Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci U S A. 1997; 94: 9320-5.
12. Piacentini L, Gray M, Honbo NY, et al. Endothelin-1 stimulates cardiac fibroblast proliferation through activation of protein kinase C. J Mol Cell Cardiol. 2000; 32: 565-76.
13. Baines CP, Zhang J, Wang GW, et al. Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res. 2002; 90: 390-7.
14. Sentex E, Wang X, Liu X, et al. Expression of protein kinase C isoforms in cardiac hypertrophy and heart failure due to volume overload. Can J Physiol Pharmacol. 2006; 84: 227-38.
15. Bates E, Bode C, Costa M, et al. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation. 2008; 117: 886-96.
16. Takano H, Hasegawa H, Nagai T, et al. Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies. Intern Med. 2003; 42: 465-9.
17. Cohn JN. Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. Circulation. 1995; 91: 2504-7.
18. Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarct size and ventricular function in rats. Circ Res. 1979; 44: 503-12.
19. Oliveira RS, Ferreira JC, Gomes ER, et al. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice. J Physiol. 2009; 587: 3899-910.
20. Pereira MG, Ferreira JC, Bueno CR Jr., et al. Exercise training reduces cardiac angiotensin II levels and prevents cardiac dysfunction in a genetic model of sympathetic hyperactivity-induced heart failure in mice. Eur J Appl Physiol. 2009; 105: 843-50.
21. Palaniyandi SS, Watanabe K, Ma M, et al. Inhibition of mast cells by interleukin-10 gene transfer contributes to protection against acute myocarditis in rats. Eur J Immunol. 2004; 34: 3508-15.
22. Stebbins EG, Mochly-Rosen D. Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C. J Biol Chem. 2001; 276: 29644-50.
23. Moustakas A, Souchelnytskyi S, Heldin CH. Smad regulation in TGF-beta signal transduction. J Cell Sci. 2001; 114: 4359-69.
24. Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med. 2008; 36: S9-16.
25. Niebauer J. Inflammatory mediators in heart failure. Int J Cardiol. 2000; 72: 209-13.
26. Palaniyandi Selvaraj S, Watanabe K, et al. Involvement of mast cells in the development of fibrosis in rats with postmyocarditis dilated cardiomyopathy. Biol Pharm Bull. 2005; 28: 2128-32.
27. Bowman JC, Steinberg SF, Jiang T, et al. Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. J Clin Invest. 1997; 100: 2189-95.
28. Roman BB, Geenen DL, Leitges M, et al. PKC-beta is not necessary for cardiac hypertrophy. Am J Physiol Heart Circ Physiol. 2001; 280: H2264-70.
29. Boyle AJ, Kelly DJ, Zhang Y, et al. Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction. J Mol Cell Cardiol. 2005; 39: 213-21.
30. Nikodemova M, Watters JJ, Jackson SJ, et al. Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII. J Biol Chem. 2007; 282: 15208-16.
31. Devaraj S, Venugopal SK, Singh U, et al. Hyperglycemia induces monocytic release of interleukin-6viainduction of protein kinase c-{alpha} and -{beta}. Diabetes. 2005; 54: 85-91.
32. Lewin I, Jacob-Hirsch J, Zang ZC, et al. Aggregation of the Fc epsilon RI in mast cells induces the synthesis of Fos-interacting protein and increases its DNA binding-activity: the dependence on protein kinase C-beta. J Biol Chem. 1996; 271: 1514-9.
33. Kawakami Y, Nishimoto H, Kitaura J, et al. Protein kinase C betaII regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. J Biol Chem. 2004; 279: 47720-5.
34. Nechushtan H, Leitges M, Cohen C, et al. Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cbeta. Blood. 2000; 95: 1752-7.
35. Ludowyke RI, Elgundi Z, Kranenburg T, et al. Phosphorylation of nonmuscle myosin heavy chain IIA on Ser1917 is mediated by protein kinase C beta II and coincides with the onset of stimulated degranulation of RBL-2H3 mast cells. J Immunol. 2006; 177: 1492-9.
36. 2+, phospholipid-dependent protein kinase associated with plasma membrane. Nature. 1983; 301: 621-3.